[GONADAL DYSGENESIS WITH FEMALE PHENOTYPE (TURNER'S SYNDROME)].
D015068:17-Ketosteroids; D045930:Anabolic Agents; D002875:Chromosomes; D003933:Diagnosis; D004958:Estradiol / Q000627:therapeutic use*; D045166:Estradiol Congeners; D004967:Estrogens; D005260:Female; D006059:Gonadal Dysgenesis; D006062:Gonadotropins; D006801:Humans; D008777:Methyltestosterone; D010641:Phenotype; D019849:Sex Determination Processes; D013256:Steroids; D014424:Turner Syndrome; D014556:Urine
D015068:17-Ketosteroids; D045930:Anabolic Agents; D045166:Estradiol Congeners; D004967:Estrogens; D006062:Gonadotropins; D013256:Steroids; D004958:Estradiol; D008777:Methyltestosterone
17-KETOSTEROIDS; ANABOLIC STEROIDS; CHROMOSOMES; DIAGNOSIS; ESTRADIOL, THERAPEUTIC; ESTROGENS; GONADOTROPINS; METHYLTESTOSTERONE; SEX DETERMINATION; TURNER'S SYNDROME; URINE
LA DISGENESIA GONADAL CON FENOTIPO FEMENINO (S'INDROME DE TURNER)